High levels of BIRC6 protein are related to poor clinical manifestations of patients with prostate cancer (PCa) [190], non-small cell lung cancer (NSCLC) [191], acute leukemia [192], and epithelial OC [35], which are related to poor prognosis. This evidence concerns the gene BIRC6 and non-small cell lung carcinoma.